New York states Department of Health (DOH) announced recently that non- white people should be prioritized over white people for anti-viral pills in short supply. The DOH announcement, dated December 27, said limited supply of oral antivirals will require providers to prioritize treatment for patients at highest risk for severe COVID-19 until more product becomes available.
Under a list of eligibility requirements for oral antiviral treatment, it said one requirement should be have a medical condition or other factors that increase their risk for severe illness and that one risk factor is being a non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding